Dr. Justin Blake Hellman, MD

Dr. Hellman practices at California Medical Surgery Center in San Luis Obispo, California.

Dr. Hellman's NPI, 1487041018, was assigned on April 21, 2015. Dr. Hellman graduated from Pritzker School of Medicine in 2015. Dr. Hellman holds California license A147716.

Dr. Hellman's primary practice is California Medical Surgery Center, at 620 California Blvd, San Luis Obispo, CA 93401. The practice phone is (805) 548-1070.

Dr. Hellman's primary practice is California Medical Surgery Center in San Luis Obispo, California. Dr. Hellman is also affiliated with Dignity Health - Marian Regional Medical Center. Dmand AI also links Dr. Hellman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hellman practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Hellman's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Hellman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Hellman's licenses on file in 4 states: California, Colorado, Michigan and Illinois.

Dmand AI lists cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and visual impairment and blindness among the conditions Dr. Hellman treats.

CMS data shows 2,619 Medicare services from Dr. Hellman across 26 procedure codes in 2024, for 667 Medicare patients. Medicare paid $309,802 for them.

CMS counts 667 Medicare patients who saw Dr. Hellman in 2024. The largest group is 65 to 74, with 315 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 13% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hellman's median patient age at 71, with 57% women.

In 2024, Dr. Hellman wrote 288 Medicare Part D claims for 151 patients. 82% of them were for generic drugs. CMS names the drug for 256 of them, across 10 drugs with 11 or more claims each, at $3,153 in total drug cost. In 2023, CMS named 150 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Hellman for performance year 2024, reported as part of a group. Dr. Hellman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of melanoma (skin cancer) excision by Dr. Hellman, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Hellman, published from 2015 to 2023. 2018 was the busiest year, with 6. The most frequent topics are Blepharoptosis and Tomography, X-Ray Computed. Dr. Hellman has published most often in Am J Ophthalmol Case Rep. Dr. Hellman's most frequent co-authors are Lily Koo Lin, MD, George John Harocopos, MD and Bilawal Mahmood, MD.

CMS Open Payments shows 17 general payments to Dr. Hellman from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 89% of the total. Alcon Laboratories Inc paid the most, $369.

Dr. Hellman graduated from Pritzker School of Medicine in 2015.

Dr. Hellman is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.